Pacific Biosciences of California (PACB) ended the recent trading session at $2.58, demonstrating a -3.37% change from the preceding day's closing price. The stock's performance was behind the S&P 500 ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a new community-developed method, CiFi, yesterday. It enables chromosome-scale, haplotype-resolved genome assemblies ...
StockStory.org on MSN
PacBio (NASDAQ:PACB) reports strong Q4 CY2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results , with sales up 13.8% year on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results